More importantly, we systematically summarize the design and discovery of small molecule inhibitors that regulate ATAD2, and the characteristics, advantages and disadvantages of these small molecules, which may provide a cornerstone for the development of ATAD2 target drugs for cancer therapy. The gene discussed is ATAD2; the disease is cancer.